Physician profile
Hal Blatman
NPI 1760529481
$13,294.07
in general payments reported to CMS, 2019-2025
16 companies · $94.41 in 2025
The $94.41 reported for 2025 was more than what a typical Preventive Medicine/Occupational Environmental Medicine provider received nationally (typical 2025 total: $76.00).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $81.99 · 2021: $129 · 2022: $69.89 · 2023: $13K · 2024: $44.91 · 2025: $94.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,318.75 |
| Food and Beverage | $576.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $12,472.42 | 2023 | Quviviq |
| Abbvie INC. | $202.92 | 2022-2025 | Qulipta, Ubrelvy |
| Collegium Pharmaceutical, INC. | $120.90 | 2020-2023 | Belbuca, Xtampza |
| Mannkind Corporation | $100.25 | 2023 | Afrezza |
| Biodelivery Sciences International, INC. | $73.53 | 2019-2021 | |
| Pfizer INC. | $58.02 | 2019-2021 | |
| Eisai INC. | $53.73 | 2020 | |
| Amgen INC. | $37.24 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $34.34 | 2025 | |
| Grt US Holding, INC. | $28.41 | 2020-2021 | |
| Dexcom, INC. | $27.38 | 2025 | Dexcom G6 Transmitter |
| Amag Pharmaceuticals, INC. | $22.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.33 | 2024 | |
| Orexo US, INC. | $13.60 | 2019 | |
| Indivior INC. | $13.40 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hal Blatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.